Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | KDM5A | P29375 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16356887 | 0.94 | MEN1 (0.39) | KMT2AMEN1TSHRRECQLDNM1 | |
| SCHEMBL16356918 | 0.93 | MEN1 (0.53) | KMT2AMEN1TSHRRECQLDNM1 | |
| SCHEMBL12423819 | 0.91 | KMT2A (0.47) | KMT2AMEN1TSHRRECQLDNM1 | |
| SCHEMBL19035553 | 0.87 | CYP1A2 (0.44) | KMT2AMEN1TSHRRECQLDNM1 | |
| SCHEMBL64411 | 0.86 | KMT2A (0.56) | KMT2AMEN1TSHRRECQLCA12 | |
| SCHEMBL64212 | 0.86 | KMT2A (0.56) | KMT2AMEN1TSHRRECQLCA12 | |
| SCHEMBL20067042 | 0.85 | MEN1 (0.42) | KMT2AMEN1TSHRRECQLDNM1 | |
| SCHEMBL12461822 | 0.85 | RECQL (0.52) | KMT2AMEN1TSHRRECQLDNM1 | |
| SCHEMBL13232030 | 0.85 | TSHR (0.44) | KMT2AMEN1TSHRRECQLDNM1 | |
| SCHEMBL21513123 | 0.84 | KMT2A (0.54) | KMT2AMEN1TSHRCA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160369064-A1 | DENDRITIC POLYMER, DENDRITIC POLYMER MONOMER, AND HYPERBRANCHED COPOLYMER | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2016-12-22 | — | — | US | disclosed |
| US-9475894-B2 | Dendritic polymer, dendritic polymer monomer, and hyperbranched copolymer | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2016-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160369064-A1 | DENDRITIC POLYMER, DENDRITIC POLYMER MONOMER, AND HYPERBRANCHED COPOLYMER | ZYX, F12, NPY5R | KMT2A 4241/4885MEN1 1421/4885TSHR 1731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.